Market research
AMST Amesite Operating Co
NASDAQ USD Technology
Latest close
As of 29 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 4M
- P/E ratio
- Not available
- Analyst target
- 7
- Dividend yield
- Not available
- Beta
- 0.99
Profile
Instrument facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Technology
- Industry
- Software - Application
- ISIN
- Not available
- Market cap
- 4M
- P/E ratio
- Not available
- Analyst target
- 7
- Dividend yield
- Not available
- Beta
- 0.99
About
About Amesite Operating Co
Amesite Inc., a technology company, engages in the development and marketing of B2C and B2B AI-driven solutions in the United States. The company products include Amesite Engage, that leverages proprietary AI infrastructure, offering cutting-edge applications that cater to both individual and professional needs; and LynkMagic, provides enterprise AI solutions for healthcare and related organizations. It also provides NurseMagic, mobile healthcare app, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situation. Amesite Inc. is headquartered in Detroit, Michigan.
Research context
Amesite Operating Co appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Technology
- Industry
- Software - Application
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the AMST discussion.
5 years, 6 months ago
From a valuation standpoint, the stock is 1347.7% more expensive than other stocks from the Technology sector with a price to sales ratio of 365.8.
Based on the above factors, Amesite Inc gets an overall score of 0/5.